Chirag Shah, MD, Director of Breast Radiation Oncology and Director of Clinical Research in the Department of Radiation Oncology at Cleveland Clinic. In this audio, he speaks about the ASCO 2022 Abstract – Assessing the benefit of adjuvant endocrine therapy in patients following breast-conserving surgery with or without radiation stratified by a 7-gene predictive DCIS biosignature.Â
Podcast Chirag Shah, MD @CShahMD @ClevelandClinic @WhitworthMD @RRabinovitch @margenthalerj ASCO22 #OncoTwitter @oncoalert Assessing The Benefit Of AET
By Editor